Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Counsyl | RCV000665192 | SCV000789266 | uncertain significance | Bloom syndrome | 2017-01-17 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002331302 | SCV002632906 | uncertain significance | Hereditary cancer-predisposing syndrome | 2022-03-30 | criteria provided, single submitter | clinical testing | The c.4252T>A variant (also known as p.*1418Kext*17), located in coding exon 21 of the BLM gene, results from a T to A substitution at nucleotide position 4252. This alteration disrupts the stop codon of the BLM gene and is predicted to preserve the native sequence while resulting in the elongation of the protein by 17 amino acids. The exact functional effect of the additional amino acids is unknown. Since supporting evidence is limited at this time, the clinical significance of this alteration remains unclear. |